Anzeige
Meldung des Tages: Goldchance mit Substanz: Warum dieses Projekt Investoren aufhorchen lässt

Telix Pharmaceuticals Aktie (ADR) News

Aktie
WKN:  A40FCQ ISIN:  US87961M1053 US-Symbol:  TLX Branche:  Pharmazeutika Land:  Australien
6,95 $
-0,01 $
-0,14%
5,8897 € 05.02.26
Depot/Watchlist
Marktkapitalisierung *
2,28 Mrd. €
Streubesitz
-
KGV
-
Faktor
1
Originalaktie
AU000000TLX2

Telix Pharmaceuticals Aktie (ADR) News

21.11.25 - PR Newswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals PR Newswire
21.11.25 - PR Newswire
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX PR Newswire
20.11.25 - PR Newswire
TLX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Telix Pharmaceuticals Ltd.
TLX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Telix Pharmaceuticals Ltd. PR Newswire
20.11.25 - PR Newswire
TLX LAWSUIT ALERT: The Gross Law Firm Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline
TLX LAWSUIT ALERT: The Gross Law Firm Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
19.11.25 - PR Newswire
Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
19.11.25 - PR Newswire
Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing
Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing PR Newswire
18.11.25 - PR Newswire
Telix Pharmaceuticals Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TLX
Telix Pharmaceuticals Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TLX PR Newswire
18.11.25 - PR Newswire
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter -- Hagens Berman
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter -- Hagens Berman PR Newswire
18.11.25 - PR Newswire
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately PR Newswire
18.11.25 - PR Newswire
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately PR Newswire
18.11.25 - PR Newswire
Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - TLX
Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - TLX PR Newswire
16.11.25 - PR Newswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm PR Newswire
14.11.25 - PR Newswire
TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class ...
14.11.25 - PR Newswire
TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX
TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX PR Newswire
13.11.25 - PR Newswire
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately PR Newswire
12.11.25 - PR Newswire
Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing
Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing PR Newswire
11.11.25 - PR Newswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm PR Newswire
11.11.25 - PR Newswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
10.11.25 - PR Newswire
TLX INVESTOR ALERT: Telix Pharmaceuticals Ltd. Investors with Substantial Losses Have Opportunity to Lead the Telix Class Action Lawsuit - RGRD Law
TLX INVESTOR ALERT: Telix Pharmaceuticals Ltd. Investors with Substantial Losses Have Opportunity to Lead the Telix Class Action Lawsuit - RGRD Law PR Newswire
07.11.25 - PR Newswire
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX PR Newswire

Newssuche

Videos

newspaper
05.02.26 +8,33%
Technical Trading: Pfund Short im Februar
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »